Ferring Pharmaceuticals Inc. v. Finch Therapeutics Group, Inc.
| FERRING PHARMACEUTICALS INC. and REBIOTIX INC. |
| FINCH THERAPEUTICS GROUP, INC., FINCH THERAPEUTICS, INC. and FINCH THERAPEUTICS HOLDINGS, LLC. |
| REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 26-2089 |
| July 30, 2026 |
| U.S. Court of Appeals, Federal Circuit |
| Patent Infringement (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 30, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Note to File: The following cases are consolidated: 26-2055 Lead with 26-2089 Cross-Appeal. The parties must file all documents in the lead appeal only. [1182708] [26-2055, 26-2089] [IMH] [Entered: 07/30/2026 11:12 AM] |
| Filing 1 Appeal docketed. Received: 07/27/2026. [1182706] . [IMH] [Entered: 07/30/2026 11:07 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
